Equine Pharmaceuticals and Supplements Market Size - Share,

The size of the global Equine Pharmaceuticals and Supplements market was worth around USD 1.45 Billion in 2024 and is predicted to grow to around USD 2.10 billion by 2032, with a compound annual growth rate (CAGR) of roughly 4.30% between 2025 and 2032. The report analyzes the Equine Pharmaceuticals and Supplements market’s drivers and restraints, as well as the impact they have on demand throughout the projection period. In addition, the report examines global opportunities in the global Equine Pharmaceuticals and Supplements market.

Equine Pharmaceuticals and Supplements Market Summary: The Equine Pharmaceuticals and Supplements Market encompasses therapeutic medications, vaccines, and dietary supplements that contribute to the treatment or prevention/management of equine health problems. Examples of such products include anti-inflammatories, dewormers, antibiotics, joint supplements, probiotics, and vitamins. Several drivers are impacting the Equine Pharmaceuticals and Supplements Market, including heightened awareness of equine health and preventive care, an increase in ownership of sport and leisure horses, a higher emphasis on performance enhancement (particularly with racehorses), and the growth of the equine industry worldwide. The Equine Pharmaceuticals and Supplements Market is also being positively impacted by advancements in veterinary formulations, an increased availability of customized supplements for specific breeds and conditions, and rising investments in animal healthcare which will continue to positively impact the Equine Pharmaceuticals and Supplements Market long-term. 

The equine pharmaceuticals and supplements market is witnessing steady growth due to rising awareness about horse health, performance enhancement, and disease prevention. The market encompasses products for joint health, digestion, immune support, and treatment of conditions like colic and lameness. Leading players such as Zoetis, Boehringer Ingelheim, and Dechra Veterinary Products are actively developing targeted therapies and advanced supplement formulations. Innovations include time-release drug delivery systems and herbal-based supplements to meet growing demand for natural solutions. Recent developments involve digital health tools for equine monitoring and expanded product portfolios for racehorses and companion horses. Increasing veterinary care standards and investments in equine sports and leisure activities are further supporting market expansion, particularly in North America, Europe, and parts of Asia.

Key Findings: 

• As per the analysis shared by our research analyst, the global Equine Pharmaceuticals and Supplements market is estimated to grow annually at a CAGR of around 4.30% over the forecast period (2025-2032). 

• In terms of revenue, the global Equine Pharmaceuticals and Supplements market size was valued at around USD 1.45 Billion in 2024 and is projected to reach USD 2.10 billion by 2032. 

• Rising awareness of equine health and preventive care is driving demand for pharmaceuticals and supplements, as horse owners increasingly invest in products that enhance longevity, performance, and overall animal well-being.

• Based on Product Type, the Pharmaceuticals segment is growing at a high rate and will continue to dominate the global market as per industry projections. 

• On the basis of Distribution Channel, the Veterinary hospitals segment is anticipated to command the largest market share. 

•  By Region, North America is projected to dominate the global market during the forecast period.

Equine Pharmaceuticals and Supplements Market Dynamics: 

The market for equine pharmaceuticals and supplements is being fueled by growing awareness of horse health, increased engagement in equestrian sports, and expanded demand for performance enhancement and preventative care. Since horses are commonly utilized for competitive sports, racing, and recreation, owners and trainers are increasingly willing to invest in specialized pharmaceuticals and nutritional supplements to help improve endurance, immunity, and overall wellness. In addition, the continuing rise in equine diseases and injuries is stimulating demand for effective treatment options and recovery products, including pharmaceuticals and supplements designed in response to clinical conditions. Advancements in veterinary medicine, such as targeted drug delivery systems, represent new opportunities for growth and also includes advancements in improved formulations and enhanced supplements. Finally, expanding veterinary healthcare infrastructure and enhanced access to quality products through online and other retail avenues will also add to this expanding market.

More and more horse owners, breeders, and trainers are paying greater attention to the health and well-being of their animals due to the increasing value of racehorses and competition horses. Campaigns and programs for equine welfare, along with veterinary advice, have increased awareness of horse health, with an emphasis on timely disease prevention, nutrition, and healthcare. This increased awareness has been a major contributor to the increasing demand for quality pharmaceuticals and supplements. Further, horse owners' increasing capacity to spend and the growth of hobbyist horse care have also supported this marketplace, as additional consumers now have an increased willingness to pay for supportive, advanced, and targeted healthcare for their equine companions.

As global popularity for equestrian competition—including racing, dressage, show jumping, and rodeo—continues to rise, these athletic activities demand significant physical exertion from horses. Physical exertion also means physical maintenance, meaning individuals who closely manage horse health, especially trainers and owners, are interested in pharmaceuticals and supplements that improve stamina, recovery, joint safety, and immune function. Monetary stakes and prestige practices in competition are influencing the focus on performance improvement. The trend is even applicable to recreational riding, where there is a greater emphasis on caring for a horse over the long-term to accomplish health as a preventative measure

Innovations continue to be made in the field of veterinary medicine, resulting in improved and preferred medications and supplements that are targeted for horses, to treat equine-specific conditions, reduce pain, and facilitate recovery, in addition to supplements that promote digestive health, hoof health, and superior muscle growth. For example, time-released dosing, injectable supplements, and organic supplements help users feel more confident in what they are giving their horses. Furthermore, companies that produce equine pharmaceuticals are investing more R&D dollars in the equine sector to develop a broader selection of products. As scientific evidence related to horse physiology matures, the equine market will have an ongoing supply of vetted, safe, and effective health solutions for our horses.

Equine Pharmaceuticals and Supplements Market: Segmentation Analysis 

Market segmentation largely occurs based on product type. As a result, pharmaceuticals account for the largest portion of the equine healthcare market, due to their essential disease prevention, treatment, and pain management abilities, such as antibiotics, anti-inflammatories, antiparasitics, and vaccines. Market estimates indicate that pharmaceuticals accounted for more than 60% of global equine health market revenue in 2024. The growing prevalence of equine diseases (colic, lameness, and respiratory diseases) has driven demand. The rising number of veterinary visits, along with the introduction of new therapeutics, for example, long-acting injectables, has propelled the pharmaceutical segment. Additionally, high-value racehorses and breeding stock tend to receive more frequent medical care, leading to continued pharmaceutical purchasing across North America, Europe, and Australia. The pharmaceutical segment dominates the equine healthcare market due to the critical role it plays in treating a wide range of diseases and injuries that directly impact horse performance, breeding, and longevity. Unlike supplements, pharmaceuticals offer regulated, evidence-based treatments for infections, joint disorders, respiratory conditions, and reproductive issues—areas vital to both sport and working horses. The segment benefits from continuous innovation, such as long-acting injectables, targeted antiparasitic drugs, and regenerative therapies like platelet-rich plasma. Companies like Boehringer Ingelheim and Dechra are introducing precision-based medications with improved dosing accuracy and reduced side effects. Moreover, stringent veterinary standards in racing and equestrian competitions require certified pharmaceuticals, further reinforcing this segment’s dominance across both developed and emerging equine markets.

The segment of equine supplements is growing quickly due to increased awareness of preventive healthcare and performance support. Equine supplements include joint health supplements, digestive supplements, coat supplements, electrolytes, and immune supplements. A report by the Animal Health Institute in 2024 stated that equine supplements are shown to grow at over 5% CAGR with North America and Europe driving consumption. Owners of competition horses and older horses are taking daily supplements to provide long-term vitality and performance function. Furthermore, the growing interest in herbal and natural formulation supplements input by health-conscious consumers is beneficial. The accessibility of supplements, and education about equine supplements through online use and nutrition brands is contributing to ongoing growth in the segment.

Veterinary hospitals are the main distribution channel, with an approximate 45% of equine health product sales worldwide in 2024, according to industry reports. These institutions deliver diagnostics and treatment, making them reliable sources of prescriptions and expensive marketing drugs. Horse owners frequently trust veterinarians with disease management and personalized supplement regimens. The increasing number of equine specialty facilities and the availability of a 24/7 emergency are key factors in sustaining this channel's dominance. As equine ownership continues to increase and equine healthcare spending rises, particularly in North America and Europe, veterinary hospitals remain the main channel for even acute care medications as well as health supplements to improve the health of the horse.

Retail pharmacies are often an easy place to access over-the-counter equine health products, especially in rural to suburban areas with significant horse ownership. This channel represented about 30% of global equine product sales in 2024.  Most retail pharmacies consist of products that horse owners will use such as dewormers, wound care products, and nutritional supplements. Retail pharmacies enjoy the advantage of having a visible brand, quick access by customers to products, and sales assistance by large animal health distributors. Retail pharmacies can further assist in emerging markets (other than North America and the European Union) where veterinarians and veterinary services are not as available. The ease of accessibility and the growing product lines of pharmaceuticals and nutraceuticals make retail pharmacies an integral component of equine health ecosystem.

Sales through the Internet now represent the fastest growing distribution channel with a projected compound annual growth rate reaching more than 7% from 2020-2024 driven by increased digital adoption by horse owners. With the growth of e-Commerce and other veterinary-specific sites, consumers are also now able to obtain selections of equine pharmaceuticals and supplements for increasingly discount prices. Daily supplements subscriptions and bulk orders through stalls are trending. Online reviews or educational content will impact consumers' purchasing decisions for equine pharmaceuticals and supplements. Especially in developed markets (eg. US, UK, Australia), online is becoming the preferred channel for consumers due to the convenience of comparison and delivery directly to the door. E-commerce growth was further accelerated by the pandemic and therefore making digital channels much more relevant.

Equine Pharmaceuticals and Supplements Market Regional Analysis:

The equine pharmaceuticals and supplements market in North America is the largest in the world, accounting for approximately 40% of global sales in 2024. This is propelled by the high equine population, advanced veterinary infrastructure, and high consumer spending on horse health. The United States is a well-established equine market alongside Canada, where there is a growing demand for preventive and therapeutic solutions. The increased focus on the equine sports sector, especially horse racing, has driven the demand for care that is specialized.

North America dominates the equine pharmaceuticals and supplements market due to its well-established equine industry, high veterinary healthcare spending, and large population of performance and companion horses. The region hosts major players like Zoetis, Merck Animal Health, and Nutramax Laboratories, which invest heavily in R\&D and innovative formulations. These companies offer advanced solutions such as targeted joint therapies, immune-boosting supplements, and easy-to-administer oral medications. The presence of equine sports, including racing and rodeo events, further drives demand for performance-enhancing and preventive care products. Strong distribution networks and growing awareness among horse owners and veterinarians also support market leadership in North America.

Emerging regions such as Asia-Pacific are witnessing significant growth, largely due to the increasing equine population, especially in China and India. Increasing disposable income, the expansion of middle-class families, and the increasing awareness of equine health will drive this demand. In the Asia-Pacific region, the growth of veterinary services and the growing popularity of horse racing will also boost the growth of the market. The Asia Pacific region is emerging as a key growth area in the equine pharmaceuticals and supplements market due to rising equestrian activities, growing disposable incomes, and increased awareness of animal health. Countries like China, India, and Australia are seeing higher demand for equine care products, driven by expanding horse racing industries and recreational riding. The growing presence of international players such as Zoetis and Boehringer Ingelheim, along with local companies introducing cost-effective, herbal-based formulations, is accelerating market development. Government support for veterinary infrastructure and increased access to veterinary professionals are further boosting adoption. Additionally, the shift toward preventive care and improved nutrition is leading to greater use of supplements focused on joint health, digestion, and immunity among both performance and leisure horses.

Europe holds a strong position in the equine pharmaceuticals and supplements market, supported by its deep-rooted equestrian culture, advanced veterinary infrastructure, and high standards of animal welfare. Countries such as the UK, Germany, France, and the Netherlands have a significant population of sport and recreational horses, fueling consistent demand for health management products. Key players like Dechra Pharmaceuticals, Vetoquinol, and Zoetis have a strong footprint in the region, offering specialized treatments for joint disorders, parasitic infections, and metabolic conditions. European firms are also focusing on developing organic and herbal supplements to align with growing preferences for natural formulations. Regulatory frameworks that ensure product quality and safety further strengthen market confidence. The presence of renowned equine events and riding schools continues to drive innovation and consistent product usage across the region.

The Middle East is becoming a promising market for equine pharmaceuticals and supplements due to the region’s deep cultural connection with horses and significant investments in equestrian sports. Countries like the UAE, Saudi Arabia, and Qatar host prestigious horse racing, endurance, and show jumping events, which drive demand for advanced veterinary care and performance-enhancing products. The growing number of horse breeding farms and equine hospitals in the region has increased the use of pharmaceuticals for treating lameness, respiratory issues, and digestive disorders. International companies such as Boehringer Ingelheim and Zoetis are expanding their presence through regional partnerships and product launches tailored for high-performance horses. Rising awareness about equine nutrition and preventive care, supported by government initiatives in animal welfare, further accelerates adoption of premium supplements and specialized medications in the Middle East.

Recent Developments: 

• 2022: AdvaCare Pharma is advancing its equine pharmaceutical offerings by expanding its product range to include supplements targeting joint health, mobility, and overall wellness. The company focuses on delivering affordable solutions for equine healthcare while maintaining high-quality standards. 

• 2021: Merck Animal Health USA continues to lead in equine health with its latest innovations in pharmaceuticals. The company has recently introduced a new line of vaccines and pain management solutions aimed at improving the overall welfare and performance of horses.

Equine Pharmaceuticals and Supplements Market: Competitive Landscape 

The global Equine Pharmaceuticals and Supplements market features major players such as AdvaCare Pharma, Merck Animal Health USA, Dechra Veterinary Products, PVS Labs, International Health Care Limited, SSS Pharmachem, Farm Vet, Pharmacon Vet Pvt.Ltd, Amino Pharma, Equistro, santa Cruz Animal Health, Soetis, among others. The Equine Pharmaceuticals and Supplements market is highly competitive, with major players such as AdvaCare Pharma, Merck Animal Health USA, Dechra Veterinary Products, PVS Labs, and others driving technological advancements across a range of applications. Companies are competing on factors such as product innovation, cost-efficiency, geographical reach, and sustainability, which are all essential for gaining market share in the growing Equine Pharmaceuticals and Supplements industry. As the market continues to expand, companies will need to focus on further improving the performance of their Equine Pharmaceuticals and Supplements and broadening their application scope to capitalize on the growing demand for energy-efficient and effective solutions in medical applications.

The competitive landscape of the equine pharmaceuticals and supplements market is evolving, with one of the leading players like Zoetis, Boehringer Ingelheim, Dechra, and Vetoquinol focusing on targeted therapies, biologics, and digital health integration. Emerging startups are entering with herbal-based and performance-specific formulations, while strategic partnerships and acquisitions are expanding geographic reach and product portfolios.

The global Equine Pharmaceuticals and Supplements market is segmented as follows:

By Product Type Segment Analysis: 

• Pharmaceuticals

• Supplements

By Distribution Channel Segment Analysis: 

• Veterinary Hospitals

• Retail Pharmacies

• Online Sales

By Region:

• North America

• U.S.

• Canada

• Mexico

• Europe

• Germany 

• France

• UK

• Spain

• Italy

• Rest of Europe

• Asia-Pacific

• China

• Japan

• India

• Australia

• South Korea

• Southeast Asia

• Rest of Asia-Pacific

• Latin America

• Brazil

• Argentina

• Rest of Latin America

• The Middle East & Africa

• GCC Countries

• South Africa

• Rest of the Middle East & Africa

Frequently Asked Questions (FAQs):

1. What is Equine Pharmaceuticals and Supplements?

Equine pharmaceuticals and supplements are specialized products designed to prevent, treat, and manage health issues in horses. These include medications for pain, inflammation, joint health, as well as nutritional supplements to enhance overall equine wellness. 

2. Which key factors will influence the Equine Pharmaceuticals and Supplements market growth over 2025-2032?

Key factors driving the equine pharmaceuticals and supplements market include increasing awareness of equine health, advancements in product formulations, growing demand for joint health support, rising horse ownership, and increasing use of supplements in competitive equine sports.

3. What will be the value of the Equine Pharmaceuticals and Supplements market during 2025-2032?

According to the study, the global Equine Pharmaceuticals and Supplements market size was worth around USD 1.45 billion in 2024 and is predicted to grow to around USD 2.10 billion by 2032.

4. What will be the CAGR value of the Equine Pharmaceuticals and Supplements market during 2025-2032?

The CAGR value of the Equine Pharmaceuticals and Supplements market is expected to be around 4.30% during 2025-2032.

5. Which region will contribute notably towards the Equine Pharmaceuticals and Supplements market value?

6. North America dominates the equine pharmaceuticals and supplements market due to a high number of horse owners, advanced veterinary care, increased awareness of equine health, and strong demand for performance-enhancing supplements in competitive horse racing. 

7. Which are the major players leveraging the Equine Pharmaceuticals and Supplements market growth?

The global Equine Pharmaceuticals and Supplements market is led by players such as AdvaCare Pharma, Merck Animal Health USA, Dechra Veterinary Products, PVS Labs, International Health Care Limited, SSS Pharmachem, Farm Vet, Pharmacon Vet Pvt.Ltd, Amino Pharma, Equistro, santa Cruz Animal Health, Soetis.

8. What can be expected from the global Equine Pharmaceuticals and Supplements market report?

The report explores crucial aspects of the Equine Pharmaceuticals and Supplements market, including a detailed discussion of existing growth factors and restraints while also analyzing future growth opportunities and challenges that impact the market.

Table of Content

1. Introduction

1. Report Description

2. Purpose of the Report

3. USP & Key Offerings

4. Key Benefits for Stakeholders

5. Report Scope

2. Executive Summary

1. Equine Pharmaceuticals and Supplements Market Snapshot

2. Global Equine Pharmaceuticals and Supplements Market, Revenue (USD Million), 2020 - 2032

3. Equine Pharmaceuticals and Supplements Market – Industry Analysis

1. Introduction

2. Market Drivers

1. Driving Factor 1 Analysis

2. Driving Factor 2 Analysis

3. Driving Factor 3 Analysis

3. Market Restraints

1. Restraining Factor 1 Analysis

2. Restraining Factor 2 Analysis

3. Restraining Factor 3 Analysis

4. Growth Opportunities

1. Opportunity 1

2. Opportunity 1

5. Porter’s Five Forces Analysis

6. Value Chain Analysis

7. PESTEL Analysis

4. Key Investment Pockets Analysis

1. Equine Pharmaceuticals and Supplements Market Attractiveness Analysis, By Region

2. Equine Pharmaceuticals and Supplements Market Attractiveness Analysis, By Product Type

3. Equine Pharmaceuticals and Supplements Market Attractiveness Analysis, By Distribution Channel

5. Competitive Landscape

1. Company Market Share Analysis – 2024

2. Global Equine Pharmaceuticals and Supplements Market: Company Revenue Market Share, 2024

3. Strategic Developments

1. Acquisitions & Mergers

2. New Product Launch

3. Regional Expansion

6. Equine Pharmaceuticals and Supplements Market – By Product Type Segment Analysis

1. Equine Pharmaceuticals and Supplements Market Overview, by Product Type Segment

2. Equine Pharmaceuticals and Supplements Market Revenue Share, By Product Type, 2024 and 2032

1. Pharmaceuticals

2. Supplements

7. Equine Pharmaceuticals and Supplements Market – By Distribution Channel Segment Analysis

1. Equine Pharmaceuticals and Supplements Market Overview, by Distribution Channel Segment

2. Equine Pharmaceuticals and Supplements Market Revenue Share, By Distribution Channel, 2024 and 2032

1. Veterinary Hospitals

2. Retail Pharmacies

3. Online Sales

8. Equine Pharmaceuticals and Supplements Market – Regional Analysis

1. Equine Pharmaceuticals and Supplements Market Overview, by Region Segment

2. Global Equine Pharmaceuticals and Supplements Market Revenue Share, By Region, 2024 and 2032

3. Regions

1. Global Equine Pharmaceuticals and Supplements Market Revenue, By Region, 2020 - 2032 (USD Million)

4. Product Type

1. Global Equine Pharmaceuticals and Supplements Market Revenue, By Product Type, 2020 - 2032 (USD Million)

5. Distribution Channel

1. Global Equine Pharmaceuticals and Supplements Market Revenue, By Distribution Channel, 2020 - 2032 (USD Million)

9. North America Equine Pharmaceuticals and Supplements Market – Country Analysis

1. North America Equine Pharmaceuticals and Supplements Market Overview, by Country Segment

2. North America Equine Pharmaceuticals and Supplements Market Revenue Share, By Country, 2024 and 2032

3. North America

1. North America Equine Pharmaceuticals and Supplements Market Revenue, By Country, 2020 - 2032 (USD Million)

2. Product Type

1. North America Equine Pharmaceuticals and Supplements Market Revenue, By Product Type, 2020 - 2032 (USD Million)

3. Distribution Channel

1. North America Equine Pharmaceuticals and Supplements Market Revenue, By Distribution Channel, 2020 - 2032 (USD Million)

1. U.S.

2. Canada

3. Mexico

10. Europe Equine Pharmaceuticals and Supplements Market – Country Analysis

1. Europe Equine Pharmaceuticals and Supplements Market Overview, by Country Segment

2. Europe Equine Pharmaceuticals and Supplements Market Revenue Share, By Country, 2024 and 2032

3. Europe

1. Europe Equine Pharmaceuticals and Supplements Market Revenue, By Country, 2020 - 2032 (USD Million)

2. Product Type

1. Europe Equine Pharmaceuticals and Supplements Market Revenue, By Product Type, 2020 - 2032 (USD Million)

3. Distribution Channel

1. Europe Equine Pharmaceuticals and Supplements Market Revenue, By Distribution Channel, 2020 - 2032 (USD Million)

1. Germany

2. France

3. UK

4. Italy

5. Spain

6. Russia

7. Rest of Europe

11. Asia Pacific Equine Pharmaceuticals and Supplements Market – Country Analysis

1. Asia Pacific Equine Pharmaceuticals and Supplements Market Overview, by Country Segment

2. Asia Pacific Equine Pharmaceuticals and Supplements Market Revenue Share, By Country, 2024 and 2032

1. Asia Pacific

1. Asia Pacific Equine Pharmaceuticals and Supplements Market Revenue, By Country, 2020 - 2024 (USD Million)

2. Product Type

1. Asia Pacific Equine Pharmaceuticals and Supplements Market Revenue, By Product Type, 2020 - 2032 (USD Million)

3. Distribution Channel

1. Asia Pacific Equine Pharmaceuticals and Supplements Market Revenue, By Distribution Channel, 2020 - 2032 (USD Million)

1. China

2. Japan

3. South Korea

4. India

5. Australia

6. Southeast Asia

7. Rest of Asia Pacific

12. Latin America Equine Pharmaceuticals and Supplements Market – Country Analysis

1. Latin America Equine Pharmaceuticals and Supplements Market Overview, by Country Segment

2. Latin America Equine Pharmaceuticals and Supplements Market Revenue Share, By Country, 2024 and 2032

1. Latin America

1. Latin America Equine Pharmaceuticals and Supplements Market Revenue, By Country, 2020 - 2032 (USD Million)

2. Product Type

1. Latin America Equine Pharmaceuticals and Supplements Market Revenue, By Product Type, 2020 - 2032 (USD Million)

3. Distribution Channel

1. Latin America Equine Pharmaceuticals and Supplements Market Revenue, By Distribution Channel, 2020 - 2032 (USD Million)

1. Brazil

2. Argentina

3. Rest of Latin America

13. Middle East Equine Pharmaceuticals and Supplements Market – Country Analysis

1. Middle East Equine Pharmaceuticals and Supplements Market Overview, by Country Segment

2. Middle East Equine Pharmaceuticals and Supplements Market Revenue Share, By Country, 2024 and 2032

1. Middle East

1. Middle East Equine Pharmaceuticals and Supplements Market Revenue, By Country, 2020 - 2032 (USD Million)

2. Product Type

1. Middle East Equine Pharmaceuticals and Supplements Market Revenue, By Product Type, 2020 - 2032 (USD Million)

3. Distribution Channel

1. Middle East Equine Pharmaceuticals and Supplements Market Revenue, By Distribution Channel, 2020 - 2032 (USD Million)

1. GCC Countries

2. Israel

3. Turkey

4. Iran

5. Rest of Middle East

14. Africa Equine Pharmaceuticals and Supplements Market – Country Analysis

1. Africa Equine Pharmaceuticals and Supplements Market Overview, by Country Segment

2. Africa Equine Pharmaceuticals and Supplements Market Revenue Share, By Country, 2024 and 2032

1. Africa

1. Africa Equine Pharmaceuticals and Supplements Market Revenue, By Country, 2020 - 2032 (USD Million)

2. Product Type

1. Africa Equine Pharmaceuticals and Supplements Market Revenue, By Product Type, 2020 - 2032 (USD Million)

3. Distribution Channel

1. Africa Equine Pharmaceuticals and Supplements Market Revenue, By Distribution Channel, 2020 - 2032 (USD Million)

1. South Africa

2. Egypt

3. Nigeria

4. Rest of Africa

15. Company Profiles

1. AdvaCare Pharma

1. Company Overview

2. Product Portfolio

3. Financial Overview

4. Recent Developments

5. Growth Strategy

6. SWOT Analysis

2. Merck Animal Health USA

1. Company Overview

2. Product Portfolio

3. Financial Overview

4. Recent Developments

5. Growth Strategy

6. SWOT Analysis

3. Dechra Veterinary Products

1. Company Overview

2. Product Portfolio

3. Financial Overview

4. Recent Developments

5. Growth Strategy

6. SWOT Analysis

4. PVS Labs

1. Company Overview

2. Product Portfolio

3. Financial Overview

4. Recent Developments

5. Growth Strategy

6. SWOT Analysis

5. International Health Care Limited

1. Company Overview

2. Product Portfolio

3. Financial Overview

4. Recent Developments

5. Growth Strategy

6. SWOT Analysis

6. SSS Pharmachem

1. Company Overview

2. Product Portfolio

3. Financial Overview

4. Recent Developments

5. Growth Strategy

6. SWOT Analysis

7. Farm Vet

1. Company Overview

2. Product Portfolio

3. Financial Overview

4. Recent Developments

5. Growth Strategy

6. SWOT Analysis

8. Pharmacon Vet Pvt.Ltd

1. Company Overview

2. Product Portfolio

3. Financial Overview

4. Recent Developments

5. Growth Strategy

6. SWOT Analysis

9. Amino Pharma

1. Company Overview

2. Product Portfolio

3. Financial Overview

4. Recent Developments

5. Growth Strategy

6. SWOT Analysis

10. Equistro

1. Company Overview

2. Product Portfolio

3. Financial Overview

4. Recent Developments

5. Growth Strategy

6. SWOT Analysis

11. Santa Cruz Animal Health

1. Company Overview

2. Product Portfolio

3. Financial Overview

4. Recent Developments

5. Growth Strategy

6. SWOT Analysis

12. Soetis

1. Company Overview

2. Product Portfolio

3. Financial Overview

4. Recent Developments

5. Growth Strategy

6. SWOT Analysis